| Heidi Yiu, | |
|
9000 Franklin Square Dr, Rosedale, MD 21237-3901 | |
| (443) 777-7179 | |
| Not Available |
| Full Name | Heidi Yiu |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 9000 Franklin Square Dr, Rosedale, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821683293 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R211785 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Hospital Center | Randallstown, MD | Hospital |
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Anesthesiology Llc | 1052678034 | 456 |
| Lifebridge Anesthesia Associates Llc | 2062514888 | 95 |
News Archive
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
Carrier screening for spinal muscular atrophy (SMA) - a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death - should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20040330000405 |
News Archive
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
Carrier screening for spinal muscular atrophy (SMA) - a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death - should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Anesthesiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528578333 PECOS PAC ID: 1052678034 Enrollment ID: O20171207001966 |
News Archive
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
Carrier screening for spinal muscular atrophy (SMA) - a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death - should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.
› Verified 7 days ago
| Entity Name | Lifebridge Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003992868 PECOS PAC ID: 2062514888 Enrollment ID: O20230627000605 |
News Archive
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
Carrier screening for spinal muscular atrophy (SMA) - a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death - should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heidi Yiu, 2809 Boston St, Baltimore, MD 21224-4814 Ph: () - | Heidi Yiu, 9000 Franklin Square Dr, Rosedale, MD 21237-3901 Ph: (443) 777-7179 |
News Archive
Del Global Technologies Corp. today announced that it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing shareholders. The rights offering will be made through the distribution of non-transferable subscription rights to purchase shares of the Company's common stock, par value $0.10 per share, at a subscription price to be determined.
Public awareness campaigns on spotting the signs and symptoms of infectious diseases and how to prevent them, play a key role in helping to stop the spread of such infections, a new study in the journal Epidemiology and Infection reports.
Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.
Carrier screening for spinal muscular atrophy (SMA) - a serious genetic disease affecting approximately 1 in 10,000 infants that causes progressive muscle weakness and death - should be made available to all families, according to a new practice guideline issued by the American College of Medical Genetics (ACMG).
The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.
› Verified 7 days ago
Cheryl Ruff, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 9000 Franklin Square Dr, Rosedale, MD 21237 Phone: 443-777-7659 | |
Ian Biblanias Mores, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4706 Stellabrooke Ln, Rosedale, MD 21237 Phone: 443-625-9790 | |
Cynthia Vanauken, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 9000 Franklin Square Dr, Rosedale, MD 21237 Phone: 443-777-7659 | |
Andrea Sellman, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9000 Franklin Square Dr, Rosedale, MD 21237 Phone: 443-777-7000 |